Vittal Vasista

Insider Reports History

Entity
Individual
Location
C/O Regenxbio Inc., 9804 Medical Center Drive, Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vittal Vasista:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Financial Officer Common Stock 247K $927K $3.76 Mar 19, 2024 Direct
REGENXBIO Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 0 Mar 19, 2024 Direct

Insider Reports Filed by Vittal Vasista

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Mar 19, 2024 2 $75.4K 4 Mar 21, 2024 Chief Financial Officer
RGNX REGENXBIO Inc. Jan 2, 2024 3 -$81.4K 4 Jan 4, 2024 Chief Financial Officer
RGNX REGENXBIO Inc. May 31, 2023 2 $29.8K 4 Jun 2, 2023 Chief Financial Officer
RGNX REGENXBIO Inc. Jan 3, 2023 3 -$30.2K 4 Jan 5, 2023 Chief Financial Officer
RGNX REGENXBIO Inc. Aug 30, 2022 1 -$72.6K 4 Aug 31, 2022 Chief Financial Officer
RGNX REGENXBIO Inc. Aug 4, 2022 2 -$622K 4 Aug 8, 2022 Chief Financial Officer
RGNX REGENXBIO Inc. Aug 1, 2022 1 -$75K 4 Aug 3, 2022 Chief Financial Officer
RGNX REGENXBIO Inc. Jul 13, 2022 2 -$144K 4 Jul 15, 2022 Chief Financial Officer
RGNX REGENXBIO Inc. Jan 20, 2022 2 $25.4K 4 Jan 24, 2022 Chief Financial Officer
RGNX REGENXBIO Inc. Jan 3, 2022 2 $0 4 Jan 4, 2022 Chief Financial Officer
RGNX REGENXBIO Inc. Jul 27, 2021 2 $8.5K 4 Jul 29, 2021 Chief Financial Officer